SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for PRECIGEN, INC. (PGEN) (CIK 0001356090) (PGEN) — May 4, 2017

PRECIGEN, INC. (PGEN) (CIK 0001356090)
Date: May 4, 2017 · CIK: 0001356090 · Accession: 0000000000-17-015719

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-216808

Date
April 21, 2017
Author
/s/ David Link for
Form
UPLOAD
Company
PRECIGEN, INC. (PGEN) (CIK 0001356090)

Letter

Mail Stop 3561 May 3 , 2017 Via E -mail Randal J. Kirk Chief Executive Officer Intrexon Corporation 20374 Seneca Meadows Parkway Germantown, Maryland 20876

Re: Intrexon Corporation Amendment No.1 to Registration Statement on Form S-4 Filed April 21, 2017 File No. 333-216808

Dear Mr. Kirk :

We have reviewed your amended registration statement and have the following comments. In our comment , we may ask you to provide us with information so we may better understand your disclosure.

Please respond to this letter by amending your registration statement and providing the requested information . If you do not believe our com ment applies to your facts and circumstances or do not be lieve an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your registration statement and the information you provide in response to this comment , we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our April 13, 2017 letter .

Material U.S. federal income tax consequences of the merger, page 87

1. We note your disclosure on page 12 and 87 stating that “it is intended, and each of Intrexon and GenV ec expect , the merger will qualify as a ‘reorganization ….” and on page 88 that “Intrexon and GenVec believe that the merger should satisfy the other technical requirements to qualify as a ‘reorganization ….” (emphasis added). We also note your statement tha t “it will not be possible to make this determination with certainty until after the closing of the merger and the expiration of the 36 -month CPR payment period.” Additionally, we note your response to comment 7 and disclosure in the filing that the tax t reatment of the merger, including treatment of the CPR’s, is unclear and uncertain. Please reconcile these statements.

Randal Kirk Intrexon Corporation May 3 , 2017 Page 2

Please contact Michael Killoy at (202) 551 -7576 or David Link at (202) 551 -3356 with any questions.

Sincerely,
/s/ David Link for

Show Raw Text
Mail Stop 3561
May 3 , 2017

Via E -mail
Randal J. Kirk
Chief Executive Officer
Intrexon Corporation
20374 Seneca Meadows Parkway
Germantown, Maryland 20876

Re: Intrexon Corporation
  Amendment No.1 to Registration Statement on Form S-4
Filed  April 21, 2017
  File No.  333-216808

Dear Mr. Kirk :

We have reviewed your amended registration statement  and have the following
comments.  In our comment , we may ask you to provide us with information so we may better
understand your disclosure.

Please respond to this letter by amending your registration statement and providing the
requested information .  If you do not believe our com ment applies  to your facts and
circumstances or do not be lieve an amendment is appropriate, please tell us why in your
response.

After reviewing any amendment to your registration statement and the information you
provide in response to this comment , we may have  additional comments.   Unless we note
otherwise,  our references to prior comments are to comments in our April 13, 2017 letter .

Material U.S. federal income tax consequences of the merger, page 87

1. We note your disclosure on page 12 and 87 stating that “it is intended, and each of
Intrexon and GenV ec expect , the merger will qualify as a ‘reorganization  ….” and on
page 88 that “Intrexon and GenVec believe  that the merger should satisfy the other
technical requirements to  qualify as a ‘reorganization ….”  (emphasis added).  We also
note your statement tha t “it will not be possible to make this determination with certainty
until after the closing of the merger and the expiration of the 36 -month CPR payment
period.”  Additionally, we note your response to comment 7 and disclosure in the filing
that the tax t reatment of the merger, including treatment of the CPR’s, is unclear and
uncertain.  Please reconcile these statements.

Randal Kirk
Intrexon Corporation
May 3 , 2017
Page 2

 Please contact  Michael Killoy  at (202) 551 -7576  or David Link at (202) 551 -3356  with
any questions.

Sincerely,

 /s/ David Link for

 John Reynolds
Assistant Director
Office of Beverages, Apparel,
and Mining
cc: Corby J. Baumann, Esq.
 Thompson Hine LLP